Login Form

Please log in to gain access to the full suite of EUROCORD-ED educational resources for members.


Webcasts

Note: to view these webcasts you need to be a registered user

World Cord Blood Congress III, Roma, Italy, October 2011

ESH - EBMT Training Course Blood and Marrow Transplantation, La Baule, France, May 2011

ESTM Cord Blood Banking Conference, Pescara, Italy, November 2009

ESH-EBMT Training Course, Latimer, UK, May 2009

ESH-Eurocord-Netcord Cord Blood Conference, Mandelieu, France, October 2008


Social media


Follow us on

Subscribe to news alert

Enter your email address:

Delivered by FeedBurner

This website is certified by Health  On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

EUROCORD-ED is the European Online Cord Blood Learning Portal for use by Doctors, Nurses, Midwives, Surgeons, UCB Processing & Testing Laboratories, Scientists and Study Groups.

Eurocord-Ed Eurocord-Ed

Archived News

66 articles available. Page : 1 2 3 4 5 6 7

1 millionth blood stem cell transplant marks major medical milestone
published 2013-03-19 20:03:07 by gluckman eliane

The Worldwide Network for Blood and Marrow Transplantation (WBMT) announced the landmark achievement today. The WBMT—a nonprofit scientific organization whose mission is promoting excellence in stem cell transplantation, stem cell donation and cellular therapy—said the 1 millionth transplant occurred in late December 2012. The finding is based on data collected by WBMT international member organizations involved in blood stem cell transplantation, which were analyzed and verified by the WBMT.

"One million transplants is a milestone that may surprise many people, because blood stem cell transplants were viewed as a rare procedure until the last decade or so," said Dietger Niederwieser, M.D., president of the WBMT and professor of medicine in the division of hematology and medical oncology at the University Hospital of Leipzig, Germany. "But important discoveries—and the vital cooperation of many scientists and physicians around the world—have dramatically improved outcomes for patients who undergo stem cell transplantation."


Direct link

Blood Press Release 4 March, 2013
published 2013-03-17 01:03:08 by gluckman eliane

Cord Blood Transplants May Be An Effective Alternative to Matched Donor Stem Cells For Children with Rare Metabolic Disorder

(WASHINGTON)- Transplants of blood-forming stem cells from umbilical cord blood may be an effective alternative to transplants of matched donor bone marrow stem cells to treat children with a rare, debilitating disease known as Hurler’s syndrome (HS), according to results of a study published online today in Blood, the Journal of the American Society of Hematology (ASH).

Click below to view the entire press release:


Direct link

EBMT April 2013 Meeting
published 2013-01-10 19:01:50 by gluckman eliane

39th Meeting of the European Group for Blood and Marrow Transplantation - 7 - 10 April 2013, London, UK

Click here for more information:

http://www.congrex.ch/ebmt2013


ESH October 2013 World Cord Blood Congress IV
published 2013-01-10 19:01:26 by gluckman eliane

monaco

 

ESH Eurocord-Ed Eurocord World Cord Blood Congress IV and Innovative Therapies for Sickle Cell Disease

October 24 - October 27, 2013 - Monaco, Principauté de Monaco       

The upcoming World Cord Blood Congress will cover a wide range of topics including cord blood transplant in adults and children, the role of HLA in cord blood transplant, stem cells, cord blood banking and regulatory issues. An international panel of distinguished scientitists and clinicians will participate in this major international forum over four days of interactive conferencing. The scientific programme will comprise a series of plenary presentations and debates. Short oral communications selected from submitted abstracts will enable registered participants to present their own data.

The World Cord Blood Congress is open to all professionals working in fields related to cord blood biology and clinical applications from both public and private sectors, including physicians, research scientists, technicians, data analysts and nurses. The congress will also be of interest to healthcare policy decision makers.

For the first time, we will have a special session on innovative therapy for sickle cell disease.

Click here for more information:

http://www.esh.org/conference/esh-eurocord-ed-eurocord-world-cord-blood-congress-iv/


ESH-EBMT April 2013 Training Course on Haemopoeitic Stem Cell Transplantation
published 2013-01-10 18:01:08 by gluckman eliane

 

ESH – EBMT Training Course on HAEMOPOIETIC STEM CELL TRANSPLANTATION

Syracuse in Sicily will host the next ESH-EBMT Training Course on Haemopoietic Stem Cell Transplantation will be held from April 25th to 28th, 2013. The meeting will be chaired by Eliane Gluckman (Paris), Tamas Masszi (Budapest), Jane Apperley (London) and Enric Carreras (Barcelona). The local host this year is Dr Giuseppe Milone (Catania).

Every year, the ESH-EBMT Training Course provides a comprehensive training in all aspects of autologous and allogeneic stem cell transplantation and comprises a mixture of formal lectures, case presentations by attendees and faculty, meet-the-expert breakfasts and dinner table discussions. For each topic an explanation of the basic principles is provided, followed by development of the subject through to the most recent advances in understanding and management. The objective of the course is to give opportunity to the attendees to have close contact and lively interaction with the teachers and the group in a nice setting. All slides will be available after the course on ESH and EBMT websites. The speakers are chosen not only for their expertise in their subject but also for their teaching skills and willingness to discuss the field of transplant in both formal and informal settings. The course is suitable for physicians at all stages of their career and is particularly useful for those in training, for those who wish to develop their current practice to a more challenging type of transplant and also as an update for established transplanters

Click here for more information:

http://www.esh.org/conference/esh-ebmt-training-course-on-haemopoietic-stem-cell-transplantation/


Register for NetCord's Cord Blood CD34 and Cell Content Webinar
published 2013-01-10 17:01:24 by gluckman eliane

InTraining

Register for NetCord's Cord Blood CD34 and Cell Content Webinar
January 31, 2013 - 1400 GMT
(9 am ET)
This webinar will be on Thursday, January 31, 2013 at 1400 GMT. Riccardo Saccardi, MD, of Careggi University Hospital Cord Blood Bank in Florence, Italy and Dr. Francesco Lanza, Director of Hematology Department, Cremona Hospital in Italy, will discuss a prospective study on behalf of Eurocord and NetCord on Cord Blood CD34. Personnel at NetCord member banks can register free of charge!
Register for the Webinar


Only One Month until the Cellular Therapy Inspection and Accreditation Workshop
Salt Lake City - February 12, 2013 - 2013 BMT Tandem Meetings
This workshop will include information on HLA typing, donor requirements in the 5th edition Cellular Therapy Standards, establishing working relationships with other departments, and cord blood administration. Separate registration from the BMT Tandem Meetings is required.
View the Preliminary Agenda

Register for the FACT Workshop 
Register for the 2013 BMT Tandem Meetings

FACT's Workshop at the ISCT Annual Meeting Includes Tracks for Cellular Therapy AND Cord Blood!
Auckland - April 22, 2013 - 2013 ISCT Annual Meeting

To maximize the opportunity to interact with our colleagues in the Asia Pacific, the workshop at the ISCT Annual Meeting will include two tracks – one for cellular therapy and one for cord blood banking. The agenda addresses current events and future challenges, including experience and advice from FACT representatives and accredited organizations. Cellular therapy programs will learn about laboratory controls, ISBT 128 implementation plans, exceptional release, and accreditation of processing hematopoietic-derived products used for immunotherapy or regenerative medicine. Cord blood presentations include validation studies, cord blood unit specifications, cord blood unit characteristics post-processing and post-thaw, and the impacts new research is having on cord blood banks. Separate registration from the ISCT Annual Meeting is required.
View the Preliminary Agenda
Register for the FACT Workshop 
Register for the 2013 ISCT Annual Meeting

 

Click here to see the upcoming events

Superior Health Council-Belgium: Cord blood for allogeneic use: Clinical and scientific aspects? (October 2012) (SHC 8784)
published 2013-01-09 13:01:04 by Baudoux Etienne


PDF / Direct link

EMTACT 2012 - HIGHLY SPECIALISED KNOWLEDGE
published 2012-05-07 10:05:55 by Nancy Hamilton

As you know, EMTACT has been posponed until October.
Please find the revised programme in .pdf.
PDF

ESH-EBMT Handbook on Haematopoietic Stem Cell Transplantation 6th Edition
published 2012-03-20 17:03:24 by Nancy Hamilton

The new fully revised 6th edition of the ESH-EBMT Handbook will be available for the first time on-site at the ESH Booth (Number 417) at the upcoming EBMT Annual Meeting in Geneva, Switzerland April 1-4, 2012.

The editors, Jane Apperley, Enric Carreras, Eliane Gluckman, Tamas Masszi and over thirty-five international contributors have completely rewritten all the chapters and updated the list of references to reflect changes in practice. Comments and suggestions from readers of the 5th edition were taken into consideration by the authors and new sections have been added. These include a chapter on JACIE and one on indications for transplant and post-transplant immunotherapy.

The remaining chapters cover topics related to haematopoietic stem cell transplantation from the history of HSCTs, their biological properties to their clinical applications in malignant and non-malignant disease. Readers will also find chapters on statistics and methodology for conducting clinical trials in Europe.

As with the 5th Edition, multiple-choice questions (MCQs) are included at the end of each chapter to allow the reader to test their knowledge. The responses to the MCQs will be available online via the Eurocord-Ed website.

It is the sincere hope of all contributors that readers will find this edition even more useful and relevant than the previous one and that it will contribute to a better understanding of HSCTs and their use in treatment of patients.

Cord Blood Related Sessions at the Annual EBMT Meeting in Geneva, Switzerland
published 2012-03-19 12:03:27 by Nancy Hamilton

The European Group for Blood and Marrow Transplantation will hold its annual meeting in Geneva, Switzerland from April 1-4, 2012. Several sessions and a multitude of abstracts, posters and oral abstract presentations will cover key and emerging issues in Cord Blood transplant, technology and clinical applications.

These will include a workshop on choosing cord blood units chaired by Annalisa Ruggeri (Paris, FR) and Vincent Kindler (Geneva, CH) in which Vanderson Rocha (Oxford, UK) and Arnon Nagler (Tel Hashomer, Il) will present respectively choosing either single, double CB unit or an intramedullary application and the how, when and for whom of cord blood transplant.

Experts Thomas Bart (Berne, CH) and Gesine Kögler (Düsseldorf, DE) will debate the affordability of cord blood banks in a “Controversy” session chaired by the Eurocord-Ed partner who leads the “Quality Assurance” section, Sergio Querol (Barcelona, ES).

The World Marrow Donor Association and EBMT will present a joint session on the challenges related to the exchange and use of HSCs for transplantation. Eurocord-Ed and WMDA president, Eliane Gluckman (Paris, FR) and EMBT president, Alejandro Madrigal (London, UK) will be chair the session. Speakers will present new data on the impact of HSCs and stem cell source on donors and recipients. Members of several Japanese transplant societies will present on the consequences of earthquakes on unrelated transplants in their country.

In addition to these cutting edge sessions, abstracts will be presented on key topics such as HLA disparity on transplant outcomes and the effect of thymosine alfa I administration on immune reconstitution.

Please visit the EMBT annual conference website for the complete programme



66 articles available. Page : 1 2 3 4 5 6 7
66 articles available. Page : 1 2 3 4 5 6 7

3rd International Congress on RSCR
published 2012-03-05 13:03:49 by Nancy Hamilton


PDF / Direct link

AusCord Survey on handling UCB units prior to transplant
published 2012-01-10 11:01:44 by Nancy Hamilton

The AusCord cord blood banks, comprising BMDI Cord Blood Bank, Queensland Cord Blood Bank and Sydney Cord Blood Bank, are conducting an evaluation of their processes with the view to harmonise their operations.  We are interested in gathering feedback from transplant centres regarding their procedures for handling the cord blood units prior to transplantation.  
We would be very grateful if you could please complete the 5-question questionnaire to be found at http://www.surveymonkey.com/s/PPTRCCV before January 31st, 2012.  Thanks for your input and we look forward to your response.


ESH Updates in Clinical Hematology
published 2012-01-09 09:01:55 by Nancy Hamilton

Professor Eliane Gluckman is one of the co-chairs of the upcoming ESH Updates in Clinical Hematology conference to be held in Paris on February 9-10, 2012 in Paris.

This conference is part of a new series features: a 1,5 day update on patient management from world class experts, a clinically and practically oriented program that reflects most recent state-of-the-art as well as innovation, in a mixture of different hematologic disorders, – in-depth presentations followed by interactive discussions, including clinical cases and controversies, and a handout comprising lecture summaries, slides and recent, selected references.

Professor Gluckman will chair the openning session on Stem Cell Transplant.  For more information and to register please follow this link.



Eurocord-Ed Policy Document on Cord Blood Banking in Europe
published 2011-12-20 05:12:15 by Nancy Hamilton

Since the first cord blood transplantation was performed in Europe in 1988, a large number of cord blood banks have been established in order to facilitate unrelated cord blood transplantation. Over the years the number of units collected in Europe has increased to approximately 190 000 in 2011. Cord blood transplantation is a rapidly growing field with an increasing number of indications worldwide. The results reported by Eurocord reflect a strikingly rapid increase in activity. For example, the Asian Pacific Blood and Marrow Transplantation Group reported 937 cord blood transplants in 2008 alone. In the USA, more than 40% of paediatric unrelated transplants are provided by cord blood.
Read more : Click here

Congrès International sur le sang de cordon ombilical présidé par E. Gluckman à  Marseille du 4 au 7 novembre 2010
published 2011-12-16 11:12:31 by Nancy Hamilton

Ces 4 journées ont réuni des scientifiques, des cliniciens et des responsables de banques de sang de cordon de tous les pays, pour confronter leurs projets, leurs études et leurs résultats.  Pour plus d'informaton:

PDF

Congrès International sur le sang de cordon ombilical présidé par E. Gluckman à Marseille du 4 au 7 novembre 2010
published 2011-12-16 11:12:23 by Nancy Hamilton

Ces 4 journées ont réuni des scientifiques, des cliniciens et des responsables de banques de sang de cordon de tous les pays, pour confronter leurs projets, leurs études et leurs résultats See .pdf for full article.
PDF

2nd Eurocord-Ed forum on LinkedIn
published 2011-12-07 09:12:34 by Nancy Hamilton

PROFESSOR ELIANE GLUCKMAN IS AVAILABLE TO ANSWER YOUR QUESTIONS ON CORD BLOOD TRANSPLANTATION

ESH  and Eurocord-Ed are very pleased to announce that Professor Eliane Gluckman will be available to respond to questions via the Eurocord-Ed linkedIn group on Thursday, December 15, 2011 from 14:30 to 15:30 Central European Time (CET). The direct link is http://www.linkedin.com/myGroups?trk=hb_side_mygrps

Hanoi workshop november 10-11, 2011.News from the international workshop on bringing hematopoietic transplantation in emerging countries
published 2011-12-02 10:12:53 by gluckman eliane

Haematopoietic stem cell transplantation has advanced to the level of being the only curative treatment for many haematological and non-haematological diseases. The frequency of stem cell transplantation varies considerably among the world regions and is dependent upon the national income and the resources devoted to health expenditures.
The primary mission of the Worldwide Network for Blood & Marrow Transplantation (WBMT, www.wbmt.org), a federation of eighteen (18) international societies involved in stem cell transplantation around the world, is to establish broad standards andassist countries with limited resources in development and performance of this curative treatment. To this end, WBMT, in association with the World Health Organization (WHO),is planning a meeting in Vietnam with the participation of health authorities from at least sixteen (16) countries with restricted resources and low transplant frequency (Gratwohl JAMA 2010). It is our goal not only to guide physicians to optimize their current stem cell transplantation activities but also to create awareness among policy makers aboutthe value of stem cell transplantation so that these activities might be expanded. Representatives from established transplant centers in countries with limited resources will also participate, with the goal of optimizing their own programs and guiding countries without experience to establish effective and resource sparing programs.

PDF / Direct link

Highlights from the 2011 World Cord Blood Congress
published 2011-12-01 06:12:44 by Nancy Hamilton

The ESH, Eurocord, Eurocord-Ed EBMT World Cord Blood Congress held in Rome, Italy from October 27-29, 2011 was a tremendous success thanks to the beautiful surroundings offered by the historic site in the city centre, the quality of the scientific programme, and the lively interaction with attendees. 
The congress took place in the centre of Rome on the Piazza Montecitorio adjacent to the Italian parliament building. Over 320 participants from fifty-two countries and from as far away as Canada, Argentina China and Australia attended the event.
The 2011 meeting focussed on Cord Blood Transplant, immunological aspects, and clinical results. All sessions were divided into three key sections: the current State-of-the-art, expert short communications, and  panel discussions.
According to attendee feedback, the possibility to discuss openly with internationally renowned specialists in both scientific and social settings was particularly appreciated   The local organizers: William Arcese, Franco Locatelli, and Paolo Rebulla all deserve special thanks as do the Staff of the European School of Haematology. Eliane Gluckman

Cord Blood: Biology, Transplantation, Banking, and Regulation
published 2011-11-30 08:11:56 by Nancy Hamilton

Cord Blood: Biology, Transplantation, Banking, and Regulation

Education and CME

The Eurocord-Ed Consortium highly recommends the recently pulblished 2011 version of  Cord Blood: Biology, Transplantation, Banking, and Regulation Edited by Hal E. Broxmeyer of the Indiana University School of Medicine and published by AABB Press. Contents include Cord Blood Biology: Hematopoiesis, Stem/Progenitor Cells, Microenvironment, Preclinical/Clinical Means to Enhance Engraftment of Cord Blood Stem Cell/Progenitor Cells, Options for the future of Regenerative Medicine, Recovery of Immune Cells in Cord Blood as well as Clinical UCB using single and double cord blood unit




66 articles available. Page : 1 2 3 4 5 6 7
66 articles available. Page : 1 2 3 4 5 6 7

News Education and CME
published 2011-11-30 07:11:05 by Nancy Hamilton


Webcasts from the recently held ESH-Eurocord- Eurocord-Ed- EBMT-Netcord World Cord Blood Congress III: Cord Blood Transplantation and Immunology of Haematopoietic Stem Cell Transplantation are now available. You will find five of the first session webcast on cord blood banking. You may either watch the webcast or view the slides in .pdf version. More webcasts will be posted shortly.

Direct link

ESH-EHA Scientific Workshop on Mesenchymal Stem Cells
published 2011-11-25 07:11:18 by Nancy Hamilton

April 20 - April 22, 2012 - Mandelieu, France

This workshop will cover Characterization of MSCS, Disease Models, Immunomodulation, Expansion of MSCS and Clinical Applications.

Participants are also encouraged to submit an abstract. Secected abstracts will be selected for short oral communications.

For more information and to register, click here



Register Now for the FACT Cord Blood Workshop, Rome, October 2011
published 2011-10-06 11:07:50 by Nancy Hamilton

Organized in conjunction with the World Cord Blood Congress 2011. Register now for:

Cord Blood Inspection & Accreditation Workshop
Wednesday, October 26, 2011

Hotel Nazionale Rome
Rome
Italy

This FACT training workshop will take place in conjuction with the World Cord Blood Congress 2011, in Rome. Register for both events by clicking on 'More Information' below.

The workshop is designed to explain the requirements for FACT-NetCord accreditation of cord blood banks. FACT representatives will be in attendance to clarify the intent of the Cord Blood Standards, provide inspectors tips for conducting inspections, and assist banks in organizing and preparing their banks for the accreditation process.

Practical application of FACT requirements stimulates discussion about effective and ineffective inspection practices and preparation techniques.

More information

ESH-EBMT Training Course on Haematopoietic Stem Cell Transplantation
published 2011-10-04 11:05:46 by Benassy Arnaud

Chairs : E. Gluckman

Date : 22-25 April 2012

Venue : Sofia, Bulgaria

Informations / Programme / Registration : Click here


BMT Tandem Meetings
published 2011-10-04 10:33:55 by Benassy Arnaud

NMDP: Radiation Disasters - Role of the BMT Team

Chair : Dennis Confer, MD

Date : February 5, 2012

Venue : Manchester, UK

Informations : Click here


New : Inauguration of the Ankara University public cord blood bank directed by Pr Meral Beksac
published 2011-09-28 13:58:47 by Benassy Arnaud

Ankara Inauguration

Allogeneic cord blood transplants are being offered to pediatric patients since 1995 in Turkey. The number of sibling-family CBTs have reached the number of twelve. The number of pediatric transplants for which the stem cell source is both cord blood and bone marrow is more: 51. Recently experience with both pediatric (n:49) and adult (n:15) unrelated cord blood transplants are amounting steadily. These number constitute approx. 3 % of all the allogeneic transplants but the trend for increase both in number and survival rates are promising. The main source of unrelated CBTs are from CBBs in Spain , NMDP, Italy and Germany. Until recently there was only autologous CB banking in Turkey limited to three private and a university CBB. In 2009 Ankara University, where the first CB storage (1994) and CBT ( 1995) was initiated was able to receive a grant that equaled to approx. 3 million euros which was spent on building a CBB with a GMP facility; renovation of the EFI accredited HLA typing laboratories, the Apheresis Unit, TRAN (Ankara University Donor Registry) and the Donor Center. The Ankara University CBB and Donor Registry are registered under BMDW for many years. Following the completion of the renovations and registration approval by the Ministry of Health, TRAN has started to recruit adult donors and cords blood donations. The grant will enable 9 000 donor (600 CB units included) costs of typing and storage. This will increase the donor and CB capacity from 4000 to 11000. On September 23 the CBB organized a opening ceremony and a scientific symposium. ESH, Eurocord and WMDA president Prof E.Gluckman and EBMT president and Anthony Nolan Director Prof A.Madrigal were the guests of honor. To an audience of 150 , the CBT experience of Turkish centers were presented which were followed by two state of art lectures by Gluckman and Madrigal. The following day a round table case discussions on best donor-CB selection was performed in the Registry site with attendees of TC coordinators. Overall the ceremony and the symposium was an important achievement in the history of transplantation in Turkey thanks to the contributions of a distinguished faculty.

Contact us
published 2011-09-27 10:11:55 by Benassy Arnaud

Pr Eliane Gluckman

eliane.gluckman@sls.aphp.fr

+33 (0) 1 42 49 96 44 or +33 (0) 1 42 49 98 26

Dr Agnes Devergie

agnes.devergie@sls.aphp.fr

+33(0) 1 42 49 96 45

Ms Didi Jasmin

didi.jasmin@univ-paris-diderot.fr

+33(0) 1 57 27 68 37

Ms Myriam Pruvost

myriam.pruvost@sls.aphp.fr

+33 (0) 1 42 49 98 26

 

 Find us on twitter https://twitter.com/#!/EurocordEd

Find us on LinkedIn http://www.linkedin.com/groups?gid=4031405&trk=myg_ugrp_ovr
 


Webcast of the ESH-EBMT Training Course on BLOOD AND MARROW TRANSPLANTATION
published 2011-07-04 10:19:36 by Benassy Arnaud

news_labaule Click here to access the webcast ofESH-EBMT Training Course onBLOOD AND MARROW TRANSPLANTATION, held in La Baule, France, 8-11 May 2011

How to use Eurocord-ed
published 2011-05-31 13:43:47 by Nancy Hamilton

Welcome to the Eurocord-Ed Website, on this page you will find information on how to use the website to find specific information relevant to your area of interest.

The website is designed to be a multilingual educational tool for vocational training destined for cord blood technicians, scientists, and clinicians including haematologists, immunologists, obstetricians, gynecologists, midwives, as well future parents and healthcare decision makers.

The information available on Eurocord-Ed comes from expert sources and has been peer-reviewed by the members of this academic Consortium.

Eurocord-Ed promotes a Blended Learning approach through provision of a broad range of relevant online learning formats and documents, and the promotion of Eurocord-Ed and other live conferences.  Documents available on the Eurocord-Ed website includes texts, slide presentations, audio-visual webcasts, clinical case studies, expert forums, and links to relevant websites.
As the field is rapidly evolving, it is important to visit the site regularly to be kept abreast of the latest information. New content is added to the site on a weekly basis.

Eurocord-Ed is a multilingual website. The ‘Regulation, Ethics, Quality’ section of the website offers content in all EU languages. All other printed information on the website can be translated by clicking in the ‘Select your Language’ function on the top right hand side of the homepage (English, French, Spanish, Italian, German). And you can translate any printed information by copying it into the Reverso tool that is freely available on the website to all Eurocord-Ed members.

The Eurocord-Ed Consortium has enriched the Reverso translation possibilities through the development of an English-Italian cord blood terminology dictionary which will allow you to reduce time and costs related to professional translation by approximately 50%. This Eurocord-Ed product will be extended to other languages in future.

IMPORTANT :

The Eurocord-Ed website is articulated around the Education/CME section. The information on all of the other sections of the website and be illustrated and completed through the many webcasted audi-visual lectures and by the powerpoint presentations prepared by international experts that you will find in this section of the website. For example, if you are more specifically interested in clinical issues related to transplantation, you will find a wealth of further information in these webcasts and powerpont presentations. The same is true for cord blood banking; for Regulatory, Ethical and Quality issues etc.

We therefore invite you to insert key works into the 'search' function to view relevant documents in different sections of the Eurocord-Ed website, in  different formats (texts, webcasts, slide presentations, newsletters etc)..

PATHWAYS:

Below you will find suggested learning scenarios and training pathways for the following groups:

  1. Technicians
  2. Scientists
  3. Clinicians Midwives, Obstetricians, Gynecologists
  4. Healthcare administrators
  5. Future Parents

1. TECHNICIANS

If you are a technician working in the field of Cord Blood technology, you will be particularly interested in the following sections of the website:

1. News and Events: subsections: News and Upcoming Events

2. Cord Blood Banking: subsections: Donation & Procurement, Processing & Preservation, Storage & Distribution, and Identification and Traceability.

3. Education and CME where you will find webcasts and slide presentations relevant to cord blood technology.

4. Regulation, Ethics and Quality subsections: International, European Union, EU Countries and American where you will find links to national authorities.

5. Expert Q & A Forum where you will find a sub-section on Cord Blood Banking for Health Care Professionals, you may use this section to ask questions to members of the Eurocord-Ed consortium.

6. Careers: If you are looking for a career in Cord Blood Banking, you will find positions announced here.

7. Contact: If you have specific questions that you would like to have answered, please contact Eurocord-Ed directly in this section.

2. SCIENTISTS

If you are a scientist working in the field of Cord Blood, you will be particularly interested in the following sections of the website:

1. News and Events: subsections: News and Upcoming Events

2. Research and Development: all subsections where you will find Current and Published results.

3. Cord Blood Banking: subsections: Donation & Procurement, Processing & Preservation, Storage & Distribution, and Identification and Traceability.

3. Education and CME where you will find slide presentations and webcasted audio-visual lectures relevant to development in basic science in the field, given by international experts.

4. Regulation, Ethics and Quality subsections: International, European Union, EU Countries and American where you will find links to national authorities.

5. Expert Q & A Forum where you will find a sub-section on Cord Blood Banking for Health Care Professionals, you may use this section to ask questions to members of the Eurocord-Ed consortium.

6. Careers: If you are looking for a career in Cord Blood, you will find positions announced here.

7. Contact: If you have specific questions that you would like to have answered, please contact Eurocord-Ed directly in this section.

3. CLINICIANS

If you are a clinician (for example haematologist, obstetrician, gynecologist or midwife) working in the field of Cord Blood, you will be particularly interested in the following sections of the website:

1. News and Events: subsections: News and Upcoming Events

2. Cord Blood Transplant: all subsections where you will find an Annotated Bibliography, Clinical Case Discussions, Ongoing studies as well as Abstracts, Posters and Short Reports.

3. Education and CME where you will find slide presentations and webcasted lectures on questions, problems and results relevant to the clinical setting given by international experts.

4 Regulation, Ethics and Quality subsections: International, European Union, EU Countries and American where you will find links to national authorities.

5. Expert Q & A Forum where you will find a sub-section on Cord Blood Transplant for Health Care Professionals. You may use this section to ask questions to members of the Eurocord-Ed consortium.

6. Careers: If you are looking for a career in Cord Blood, you will find positions announced here.

7. Contact: If you have specific questions that you would like to have answered, please contact Eurocord-Ed directly in this section.

4. HEALTH CARE ADMINISTRATOR

If you are a health care administrator working in the field of Cord Blood you will be particularly interested in the following sections of the website:

1. News and Events: subsections: News and Upcoming Events

2. Regulation, Ethics and Quality subsections: International, European Union, EU Countries and American legislation and policy as well as contact information for relevant authorities.

3. Education and CME where you will find webcasts and slide presentations relevant to regulation, ethics and quality standards?  

4. Expert Q & A Forum where you will find a sub-sections for Health Care Professionals, you may use this section to ask questions to members of the Eurocord-Ed consortium.

5. Careers: If you are looking for a career in Cord Blood, you will find positions announced here.

6. Contact: If you have specific questions that you would like to have answered, please contact Eurocord-Ed directly in this section.

5. FUTURE PARENTS

Eurocord-Ed is a vocational training tool. However, some of the information available on the site may be of interest to certain future parents. The information available on Eurocord-Ed comes from expert sources and has been peer-reviewed by the members of this academic Consortium.

If you are are a future parent interested in  working in the field of Cord Blood you may be particularly interested in the following sections of the website:

1. News and Events: subsections: News and Archived News.

2. Regulation, Ethics and Quality subsections: International, European Union, EU Countries and American where you will find links to national authorities.

3. Expert Q & A Forum where you will find a sub-sections for the General Public, you may use this section to ask questions to members of the Eurocord-Ed consortium.

5. Partners: in the subsection Other Organisations, you will find information for future parents who would like to donate their umibilical cord blood.

6. Contact:
If you have specific questions that you would like to have answered, please contact Eurocord-Ed directly in this section.

REGISTER NOW FOR THE WORLD CORD BLOOD CONGRESS III
published 2011-05-25 15:30:23 by Benassy Arnaud

roma

CORD BLOOD TRANSPLANTATION ANDIMMUNOBIOLOGY OF HAEMATOPOIETIC STEM CELL TRANSPLANT

27 - 29 October, Rome, Italy

Click here to retrieve the programme and register

About Rome, the Eternal City




66 articles available. Page : 1 2 3 4 5 6 7
66 articles available. Page : 1 2 3 4 5 6 7

Cord Blood Workshop
published 2011-05-25 14:50:58 by Benassy Arnaud

fact_banner

Register for the Cord Blood Workshop at the International Umbilical Cord Blood Symposium to learn how to prevent common citations! Presenters at this workshop on June 26, 2011 in San Francisco, California will address difficult requirements for cord blood banks with candid, practical information. Do you have questions or concerns about any of the following:

  • Planning, conducting, and documenting acceptable validation studies?
  • Controlling collection supplies and reagents at fixed and/or non-fixed collection sites?
  • Providing transplant centers with information regarding handling and thawing the cord blood unit, especially in accordance with the FDA guidance?
  • Knowing when to test what samples, and which tests to perform?
  • How to prepare your bank for a FACT-NetCord inspection?
  • How to become a FACT Cord Blood Inspector?

Revision of the Clinical Trials Directive 2001/20/EC Concept Paper for Public Consultation
published 2011-05-12 11:20:39 by Nancy Hamilton

The European Commission is planning to put forward, in 2012, a legislative proposal to revise the Clinical Trials Directive 2001/20/EC.
This concept paper pdf - 94 KB [94 KB] is being put out for public consultation. It presents:

  • a 'preliminary appraisal' of which option appears to be the most suitable one to address some of the key concerns of the Clinical Trials Directive, on the basis of the current state of the impact assessment; and
  • the main figures that are being used to evaluate the impacts of the different policy options.
Published May 12, 2011

Human Umbilical Cord Blood for Wound Repair
published 2011-05-10 15:10:15 by Nancy Hamilton

An article in "Wound Repair and Regeneration - The International Journal of Tissue Repair and Regeneration" authors report on the "Promotion of cutaneous wound healing by local application of mesenchymal stem cells derived from human umbilical cord blood" to view the full article, please click here Published May 10, 2011

European Medicines Agency releases new guidance on medicines based on SCs
published 2011-05-06 14:41:20 by Nancy Hamilton

The European Medicines Agency has released new guidance on medicines based on stem cells. The guidance covers the different types of stem cells used in medicines, and the considerations that companies need to take into account when developing medicines including stem cells or developed from stem cells.
The reflection paper on stem cell-based medicinal products (available here) stresses the fact that companies developing medicines including stem cells need to pay close attention to the way the medicines are manufactured, to make sure that the final medicine is as consistent and reproducible as possible.
Pre-clinical and clinical testing also needs to take account of the cells' properties, ensuring that the possible risks of tumour development and rejection by the body are studied adequately and balanced against their benefits for patients.
Stem cells are naturally occurring cells in the body that have the ability to divide and produce a range of different cell types. The use of stem cells as medicines is a promising area of research as they may be able to help the body to regenerate damaged or lost tissue in diseases like Parkinsons disease, multiple sclerosis, heart disease, liver disease, spinal cord damage or cancer.
The reflection paper was adopted by the Agency's Committee for Advanced Therapies (available here ) (CAT) on 14 January 2011. This followed a public consultation between March and June 2010 (see the overview of comments here ) and discussion at a public workshop in May 2010 here involving 230 participants from academia, industry and regulatory authorities. Published on May 6, 2011

Testing Power of Cord Blood
published 2011-05-06 13:28:22 by Nancy Hamilton

Researchers at Monash Medical Centre in Melbourne, Australia, are awaiting approval for a study that would use umbilical-cord blood to treat 20 children with cerebral palsy. The researchers want to evaluate
whether cord blood can cure or alleviate symptoms of the disease. The trial is expected to commence this year. Click here to read the full article at www.theage.com.au Published May 6, 2011

WHO Transplantation of human cells, tissues and organs
published 2011-05-05 15:20:50 by Nancy Hamilton

The World Health Organisation presents their guidelines for transplantation of human cells, tissues and organs. According to the WHO "In 50 years, transplantation has become a successful worldwide practice. However, there are large differences between countries in access to suitable transplantation and in the level of safety, quality, efficacy of donation and transplantation of human cells, tissues and organs. The ethical aspects of transplantation are at the forefront. In particular, the unmet patients needs and the shortage of transplants lead to the temptation of trafficking in human body components for transplantation." Download the WHO's "Guiding Principles" via this link. Published May 5, 2011

Interview highlights from EBMT Annual Meeting 2011 in French and English
published 2011-05-04 09:54:11 by Nancy Hamilton

Please find slide presentations and interview summaries of the major highlights from the recent EBMT Annual Meeting held in Paris in April 2011 by clicking here.

Retrouvez la synthse des communications majeures du Congrs EBMT 2011 sous forme de diaporamas et d'interview d'experts en suivant ce lien.

ESH-EBMT Handbook on Haemopoietic Stem Cell Transplantation
published 2011-04-22 10:22:44 by Nancy Hamilton

The ESH-EBMT Handbook (2008 edition) is available at the following Link: ESH-EBMT Handbook on Haemopoietic Stem Cell Transplantation

World Cord Blood Congress III: Cord Blood Transplantation and Immunobiology of HSCT
published 2010-11-22 10:40:43 by Benassy Arnaud

Venue: Rome, Italy
Date: 27-30 October, 2011

ESH-Eurocord-Eurocord-Ed President: E. Gluckman
Eurocord-Ed Local Local Organizers: W. Arcese, F. Locatelli, P. Rebulla
EBMT Immunobiology Working Party: A. Madrigal, A. Toubert, A. Velardi
Netcord: E. Baudoux, C. Navarrete

Registration: http://www.esh.org

WBMT - Hanoi, Vietnam
published 2010-11-22 10:38:06 by Benassy Arnaud

Venue: Hanoi, Vietnam
Date: 10-11 November 2011

Informations : www.wbmt.org
Registration : Retrieve file



66 articles available. Page : 1 2 3 4 5 6 7
66 articles available. Page : 1 2 3 4 5 6 7

FACT Workshop Agenda November 2010
published 2010-08-31 13:10:36 by Benassy Arnaud

encart_fact Click here to retrieve the Workshop Programme for Fact Workshop, to be held in Marseille, France, November 3, 2010

World Cord Blood Congress Presentations
published 2010-04-23 10:27:01 by Benassy Arnaud

encart_marseille

Click here to read the selected presentations fromWORLD CORD BLOOD CONGRESS, held in Marseille, France, 4-7 November 2010.

'Cord blood saving lives' : CNN Report
published 2010-04-14 09:57:21 by Benassy Arnaud

CNN's Dr. Sanjay Gupta reports on how blood from umbilical cords can save the lives of cancer patients.

View video published on March 2, 2010 on CNN Website

Adult somatic stem cells - new perspectives, Monaco 2009
published 2010-04-13 15:45:28 by Benassy Arnaud

monaco_encart
To view presentations from the Adult somatic stem cells - new perspectives conference held in Monaco, November 2009click here.

(Note: you need to be aregistered member to view this content. Registration is free.)

Eurocord 2009 Achievements
published 2010-04-09 13:34:52 by Administrator

Read about Eurocord's 2009 Achievements

Eurocord 2009 Achievements
published 2010-04-09 13:04:18 by Administrator

Eurocord is an international registry of cord blood transplants established in Paris, in 1995 under the direction of Dr Vanderson Rocha and Professor Eliane Gluckman. It has currently collected and validated more than 6000 cases of cord blood transplants throughout the world with approximately 70% provided by EBMT transplant centers.

EUROCORD collaborates closely with cord blood banks and EBMT centres, collecting and validating clinical data of patients transplanted with Netcord cord blood units, or receiving a cord blood transplant in an EBMT centre. This collaboration is important in order to evaluate the quality of the cord blood unit and to help cord blood banks to follow national and international system accreditation.

EUROCORD also collaborate with EBMT working parties in observational studies. In 2009, the EBMT Registry has finalized a data agreement with the EUROCORD Registry, to improve data collection in Promise. The agreement facilitates the data flow, enabling EBMT centres to submit their cord blood data once, instead of to both organizations.

In December 2009, in order to collect data of American patients receiving a European cord blood graft and vice-versa, an agreement between Eurocord-EBMT and CIBMTR was established to share clinical data outcome through the implementation of AGNIS project. AGNIS is "A Growable Network Information System", which has the goal to transmit haematopoietic stem cell transplant (HCT) data between different data bases. This project was approved and financed by the American government and it is in currently development between Eurocord and CIBMTR.

In 2009, Eurocord registry has published many articles (see below) in collaboration with EBMT working parties and National Societies. Two abstracts were accepted in the EBMT plenary session in Goteborg 2009. Prospective trials in collaboration with The French Society of HSCT (SFGM-TC) have started. Many other observational studies are on going. The main task of the Eurocord registry in 2010 is to finalize the AGNIS project and to continue and establish collaborations with cord blood banks and EBMT working parties. Many observational studies are on going and we hope to finalize most of them.

Eurocord Achievements 2009, studies and publications

  1. Plenary session of EBMT 2009
    Comparison of outcomes after intrabone versus intravenous CBT (F Frassoni)
    Reduced intensity UCBT for adults, on behalf of Eurocord and SFGM-TC (B Rio)
  2. Prospective studies in collaboration with the French society of bone Marrow transplant and cell therapy (SFGM-TC)
    RIC -UCBT for patients with AML (B Rio, PHRC): Finished recruitment
  3. Single vs Double CBT in children and young adults with acute leukemias (G Michel, PHRC, France): approved but not yet started

    Double CBT for Lymphoid malignancies (PHRC Cancer V Rocha, submission)

  4. Submitted /on going retrospective studies/proposals

Unrelated CBT for children with MDS- Leukemia, under review A Madureira/F Locatelli on behalf of Eurocord, CIBMTR and EWOG
Unrelated CBT for adults with MDS, Blood. M Robin on behalf of Eurocord and CLWP

Analysis completed and manuscripts on-going

Related CBT for children with malignant disorders AL Herr/ N Kabbara
HLA identical BM versus CB for patients with thal and SCID F Locatelli
MAC and single UCBT for adults with leukemia H Bittencourt/S Nabhan
Haplo versus CB for PID (coll. with IEWP) J Fernandes/ M Calvo
Graft failure after UCBT J Fernandes
UCBT for aplastic anemia (coll. AWP) RP de La Tour/ D Purtill
UCBT for congenital aplastic anemia (coll. AWP) R Bizetto
HLA allele-typed UBM vs UPB vs UCB in adults with AL (CIBMTR) M Eapen/V Rocha
RIC-CBT (SFGM-TC) B Rio/ V Rocha


Data collection and analysis on-going

UCBT-RIC versus UBMT-RIC for lymphoma (coll. LWP) C Arrais
HLA identical vs UBM vs UCB in Hurler's Synd. J Boelens/J Kurtzberg
KIR in other malignant and non malignant disorders( coll. IBWP) A Ruggeri/ R Willemze
NIMA and UCBT outcomes (coll. IBWP) D Purtill
UCBT for ALL in adults S Furst/ D Purtill
UCBT for ALL in children A Ruggeri/JH Dalle
Chronic GVHD and Late effects after UCBT A Crotta
Autoimmune diseases after UCBT T Daikeler
Intrabone versus IV CBT F Frassoni
Effect of HLA locus mismatch in CBT outcomes D Purtill
Unrelated CBT for hemoglobinopathies V Rocha/M Eapen/ A Ruggeri
Unrelated CBT for malignant disorders in Brazil (coll SBMTO) C Arrais

Other on-going international collaborative studies

Influence of HLA-C on engraftment (Netcord/CIBMTR-NMDP) M Eapen/V Rocha

Other proposals

Antibodies anti HLA and outcomes after UCBT P Loiseau-SFGM-TC
Relevance of cytokine/immune response gene polymorphisms in UCBT E Petersdorf
Clinical importance of MHC haplotypes in UCBT E Petersdorf
Identification of functional SNPs in UCBT E Petersdorf
Worldwide survey of UCBT (wBMT) Eurocord/NYBC/CIBMTR/Asian-Pacific Registry
Bank effect on outcomes: Netcord banks H Bittencourt/V Rocha
Infections M Robin, JP Yves, F Legrand/I Ionescu


4. Publications: 2009

  1. Rocha V, Broxymeyer H. New approaches for improving engraftment after Cord Blood Transplantation.Biol Blood Marrow Transplant. 2009 Nov 4. [Epub ahead of print]
  2. Rocha V, Kabbara N, Ionescu I, Ruggeri A, Purtill D, Gluckman E. Pediatric related and unrelated cord blood transplantation for malignant diseases.Bone Marrow Transplant. 2009 Nov;44(10):653-9. Epub 2009 Oct 5.
  3. Rocha V, Gluckman E; Eurocord-Netcord registry and European Blood and Marrow Transplant group. Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft- and transplantation-related factors.Br J Haematol. 2009 Oct;147(2):262-74.
  4. Barker JN, Rocha V, Scaradavou A. Optimizing unrelated donor cord blood transplantation.Biol Blood Marrow Transplant. 2009;15 (1 Suppl):154-61.
  5. Willemze R, Rodrigues CA, Labopin M, Sanz G, Michel G, Soci G, Rio B, Sirvent A, Renaud M, Madero L, Mohty M, Ferra C, Garnier F, Loiseau P, Garcia J, Lecchi L, Kgler G, Beguin Y, Navarrete C, Devos T, Ionescu I, Boudjedir K, Herr AL, Gluckman E, Rocha V. KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia. Leukemia. 2009 , 23:492-500.
  6. Rodrigues CA, Sanz G, Brunstein CG, Sanz J, Wagner JE, Renaud M, de Lima M, Cairo MS, Frst S, Rio B, Dalley C, Carreras E, Harousseau JL, Mohty M, Taveira D, Dreger P, Sureda A, Gluckman E, Rocha V.Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation. J Clin Oncol. 2009 ;27:256-63.
  7. Boelens JJ, Rocha V, Aldenhoven M, Wynn R, O'Meara A, Michel G, Ionescu I, Parikh S, Prasad VK, Szabolcs P, Escolar M, Gluckman E, Cavazzana-Calvo M, Kurtzberg J; EUROCORD, Inborn error Working Party of EBMT and Duke University. Risk factor analysis of outcomes after unrelated cord blood transplantation in patients with hurler syndrome. Biol Blood Marrow Transplant. 2009;15:618-25.
  8. Gluckman E, Rocha V. Cord blood transplantation: state of the art. Haematologica. 2009 ;94:451-4.
  9. Rocha V, Mohty M, Gluckman E, Rio B; Eurocord; Reduced-Intensity Conditioning Subcommittee of the Acute Leukaemia Working Party; French Society of Bone Marrow Transplantation and Cellular Therapy. Reduced-intensity conditioning regimens before unrelated cord blood transplantation in adults with acute leukaemia and other haematological malignancies. Curr Opin Oncol. 2009 Jun;21 Suppl 1:S31-4.


36th Annual Meeting of the European Group for Blood and Marrow Transplantation
published 2010-04-09 10:47:55 by Benassy Arnaud

encart

Donate your Cord Blood
published 2010-02-23 11:00:25 by Administrator

Italian Brochure on UCB Donation

Free webinar: Cord Blood Potency, Quality and Release: Assays Compliant with FDA Regulations
published 2010-02-16 16:59:02 by Administrator

Click to enlarge

cord_blood_potency_smallUmbilical cord blood is now considered a drug by the FDA.

The new Guidance for Industry: Minimally Manipulated, Unrelated Allogeneic Placental/Umbilical Cord Blood Intended for Hematopoietic Reconstitution for Specific Indications requires cord blood banks to measure identity, potency (strength) and quality of cord blood prior to its intended use. The parameters recommended by FDA/CBER are often at odds with, and in many cases, apparently contradictory to, the regulations. The Guidance allows for an "alternative approach" and other comparable and equivalent assays to be performed, providing the assays have been validated.

This webinar discusses the recommended assays in the Guidance and alternative, validated assays that have been designed specifically for the intended purpose.

Register (this will bring you to a site outside of Eurocord-ed.org):

Wed, Feb 17, 2010 9:00 AM - 10:00 AM MST (5pm GMT)

Wed, Mar 3, 2010 9:00 AM - 10:00 AM MST(5pm GMT)

Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution
published 2010-02-08 17:09:58 by Administrator

Authors: Colleen Delaney, Shelly Heimfeld, Carolyn Brashem-Stein, Howard Voorhies, Ronald L Manger & Irwin D Bernstein

Read article in Nature.



66 articles available. Page : 1 2 3 4 5 6 7
66 articles available. Page : 1 2 3 4 5 6 7

'I wanted my baby's cord blood to save'
published 2010-02-04 15:37:54 by Administrator

BBC News

January 18, 2010

When Natalie Salama-Levy gives birth to her second child at the end of next month she wanted to be able to donate its cord blood. But despite the fact that she is prepared to donate to help others, she cannot.

View article on BBC News website

NetCord-FACT International Standards for Cord Blood Collection, Banking, and Release for Administration
published 2009-12-29 11:26:31 by Administrator

SIGNIFICANT CHANGES FROM THIRD EDITION TO FOURTH EDITION

View document pdf_button

ESBB Annual Meeting, Marseille, 16-19 November 2011
published 2009-12-18 09:57:47 by Administrator

Conference theme: "Identifying the challenges and the opportunities for biorepositories today and in the next five years".

Confirmed speakers include: Christian Brchot, Ann Cambon-Thomsen, Fay Betsou, Uwe Oelmuller, Kurt Zatloukal, Ole Seburg, Jim Vaught and Georges Dagher.

Registration, exhibitor and sponsor information now available: http://www.esbb.org/meetings.html

EUROCORD-ED and TRANSMED: Transfusion Medicine, Cellular and Tissue Therapies link up to share online resources
published 2009-10-16 13:52:08 by Administrator

transmed

TRANSMED is a curriculum development project funded by the Lifelong Learning Program of the European Commission. Its goal is to design a European master program in Transfusion Medicine. EUROCORD-ED and TRANSMED projects share many key partners including the University of Lige (Belgium), the European School of Haematology (France), the Foundation Ospedale Maggiore Policlinico-Mangiagalli e Regina Elena (Italy), and the Blood and Tissue Bank of Catalonia (Spain). To learn more about TRANSMED, please visit www.transmederasmus.eu

Cord Blood Saved My Life
published 2009-08-24 16:55:19 by Administrator

A website from one of the first patients transplanted for Fanconi Anemia with UCB from a HLA identical sister

www.nataliecurry.com

A European Model for Life Long Learning in Bio-Medical Science
published 2009-05-22 08:42:24 by Administrator

Read the article here pdf_button

Profile of the Mandelieu Cord Blood Conference October 2008
published 2009-04-30 14:37:46 by Administrator

Read a profile of the Mandelieu Cord Blood Conference October 2008 pdf_button

EUROCORD-ED in the news
published 2009-04-28 10:14:44 by Administrator

Head of Haematology at Eurocord Dr Eliane Gluckman describes the development of a network to support and promote the use of cord blood, and the training required in technology and transplantation.

Published in the UK Public Service Review, Issue 17.

The Eurocet Project
published 2009-04-17 10:20:15 by Administrator

Article 10, paragraph 2 of the European Directive 2004/23/EC requires the Competent Authority to establish and maintain a publicly accessible register of tissue establishments specifying the activities for which they have been authorised. In addition, paragraph 3 states "Member States and the Commission shall establish a network linking the national tissue establishment registers".

The Eurocet Project, which was funded by the European Commission, has established The Eurocet Registry which will include the name and address of the Tissue Establishment, and the type of tissue and / or cell to which the authorisation pertains. More information on the Eurocet Registry can be found at: www.eurocet.org.

Copenhagen Quality Assurance in VET
published 2009-03-09 10:41:47 by Administrator

Fundamentals of a Common Quality Assurance Framework (CQAF) for Vocational Educational Training in Europe

View document pdf_button



66 articles available. Page : 1 2 3 4 5 6 7
66 articles available. Page : 1 2 3 4 5 6 7

Eurocord-Ed Photos From 20th Anniversary Celebrations
published 2009-03-06 19:15:48 by Administrator

Click here to see photographs from the Mandelieu conference

Published March 6, 2009

Focus on Banking
published 2009-03-06 18:53:33 by Administrator

The Ospedale Maggiore hospital in Milan was originally founded in 1456. The "Policlinico" (General Hospital), Mangiagalli and Regina Elena Ospedale Maggiore Foundation was officially opened in 2005. The mission of exploiting the potentials of cellular therapy and of performing biobanking research was given to a unit named the Center of Transfusion Medicine, Cellular Therapy and Cryobiology (CTMC).

Currently, the CTMC includes five sections: one of which includes the Milano Cord Blood Bank, with an inventory of 6627 allogeneic cord blood units, 350 of which have been transplanted in 21 countries (39 units in 2007). Published March 6, 2009

Latimer '09 Webcasts
published 2009-03-06 18:49:36 by Administrator

webcast_latimer uk_may09To view 8 presentations from The 13th ESH-EBMT Training Course on Blood and Marrow Transplantation held in Latimer, UK, May 25-28, 2009 click here.

(Note: you need to be a registered member to view this content)

Pescara '09 Webcasts
published 2009-03-06 18:49:36 by Administrator

webcast_pescara_nov09_2To view presentations from the Organisational, Technical and Clinical aspects of Cord Blood Banking conference held in Pescara, Italy, November 11-15 2009 click here.

(Note: you need to be a registered member to view this content. Registration is free.)

Advanced Therapy Medicinal Products (ATMP) Regulations 1394/2007/EC 20th February, 2009
published 2009-03-06 18:31:46 by Administrator

An ATMP is a medicinal product as defined in Directive 2001/83/EC and is either:

  • a gene therapy medicinal product as defined in Part IV of Annex I to Directive 2001/83/EC;
  • a somatic cell therapy medicinal product as defined in Part IV of Annex I to Directive 2001/83/EC; or
  • a tissue engineered product as defined in Article 2 1 (b) of the ATMP Regulation (1394/2007/EC).

All final and draft guidelines are published on the EMEA Advanced Therapies webpage To view the ATMP regulation 1394/2007/EC click here pdf_button

New publication on the History of Cord Blood Transplantation by Eliane Gluckman
published 2009-03-06 18:04:35 by Administrator

Since the first human cord blood transplant, performed twenty years ago, cord blood banks have been established worldwide for collection and cryopreservation of cord blood for allogeneic hematopoietic stem cell transplant. A global network of cord blood banks and transplant centers has been established for a common inventory and study of clinical outcomes.

Read full article



66 articles available. Page : 1 2 3 4 5 6 7